Načítá se...

Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key

Triple negative breast cancer (TNBC) accounts for 15%-20% of all breast cancer, and is still defined as what it is not. Currently, TNBC is the only type of breast cancer for which there are no approved targeted therapies and maximum tolerated dose chemotherapy with taxanes and anthracycline-containi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Clin Oncol
Hlavní autoři: Rabanal, Connie, Ruiz, Rossana, Neciosup, Silvia, Gomez, Henry
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740099/
https://ncbi.nlm.nih.gov/pubmed/29291168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v8.i6.437
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!